Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial
Abstract Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of some chemotherapy regimens. Lithium has been suggested for CIPN in some animal studies. We aimed to study lithium’s preventive effect on CIPN in breast cancer patients treated with taxanes and platinu...
Enregistré dans:
Auteurs principaux: | S. Najafi, Z. Heidarali, M. Rajabi, Z. Omidi, F. Zayeri, M. Salehi, S. Haghighat |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/69e2cadfe47f45b0b317ff23a30c1f8e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
par: Nicolas Kerckhove, et autres
Publié: (2021) -
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
par: Sandy Eldridge, et autres
Publié: (2021) -
EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
par: I Putu Eka Widyadharma, et autres
Publié: (2021) -
An adolescent rat model of vincristine-induced peripheral neuropathy
par: Ai-Ling Li, et autres
Publié: (2021) -
Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
par: Matthew R. Trendowski, et autres
Publié: (2021)